SABS
SAB BIOTHERAP (SABS)
NASDAQ
$3.53+$0.12 (+3.52%)
Price as of Sep 11, 2026 7:30 PM EDT
  • $310.3M
    Market Cap
  • 60.85%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
Valuation
SABS
vs History
vs S&P 500
Profitability
-1
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 47
Valuation
SABS
vs History
vs S&P 500
3-Month Momentum
13.10%
12-Month Momentum
79.25%
3-Month Risk Adjusted Momentum
54.26%
12-Month Risk Adjusted Momentum
115.26%

True Yield

N/A
Valuation
SABS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
0.60%

Financial Health Score

N/A
Valuation
SABS
vs History
vs S&P 500
Ohlson's O-Score
2